| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| daratumumab cybord for multiple myeloma | 0.53 | 0.8 | 8227 | 37 | 39 |
| daratumumab | 1.75 | 0.7 | 5449 | 42 | 11 |
| cybord | 1.52 | 0.9 | 1853 | 17 | 6 |
| for | 1.58 | 0.6 | 6631 | 19 | 3 |
| multiple | 1.84 | 0.1 | 2313 | 76 | 8 |
| myeloma | 1.08 | 0.3 | 5279 | 63 | 7 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| daratumumab cybord for multiple myeloma | 1.42 | 0.4 | 8316 | 77 |
| daratumumab for multiple myeloma | 1.35 | 0.8 | 2446 | 76 |
| daratumumab treatment for multiple myeloma | 0.87 | 0.4 | 5868 | 29 |
| dara cybord multiple myeloma | 1.97 | 0.1 | 8029 | 12 |
| daratumumab maintenance multiple myeloma | 0.62 | 1 | 280 | 76 |
| daratumumab maintenance for myeloma | 1.45 | 0.8 | 2577 | 5 |
| cybord regimen for multiple myeloma | 0.26 | 0.4 | 8921 | 96 |
| daratumumab multiple myeloma nice | 0.94 | 0.2 | 2764 | 24 |
| daratumumab and carfilzomib multiple myeloma | 1.04 | 0.1 | 8457 | 8 |
| daratumumab first line myeloma | 1.28 | 0.7 | 9664 | 34 |
| daratumumab dexamethasone multiple myeloma | 0.43 | 0.7 | 4876 | 49 |
| multiple myeloma daratumumab immunofixation | 1.52 | 0.4 | 4857 | 94 |
| when was daratumumab approved for myeloma | 1.16 | 0.3 | 8355 | 57 |
| denosumab for multiple myeloma | 0.29 | 0.2 | 9354 | 35 |
| bortezomib in multiple myeloma | 0.76 | 0.3 | 6896 | 37 |
| daratumumab for cancer patients | 1.12 | 0.9 | 6304 | 90 |
| daratumumab for cancer treatment | 1.8 | 1 | 8652 | 16 |
| daratumumab type and screen | 0.27 | 0.2 | 7415 | 29 |
